AstraZeneca: COVID vaccine 79% effective in U.S. trial - Morning Briefing - Marketplace Minute - March 22, 2021

Drugmaker says vaccine fully prevents severe COVID illness; IMF to upgrade world economic forecast; Canadian Pacific Railway strikes deal to purchase Kansas City Southern for $25 billion To learn more about listener data and our privacy practices visit: https://www.audacyinc.com/privacy-policy Learn more about your ad choices. Visit https://podcastchoices.com/adchoices